Brigham and Women's Hospital
Boston, MA, United States
Sara Tedeschi, MD, MPH is a rheumatologist and clinical investigator at Brigham and Women’s Hospital and an Assistant Professor of Medicine at Harvard Medical School. After receiving her medical degree from Vanderbilt University School of Medicine, she completed her internal medicine residency and rheumatology fellowship training at Brigham and Women’s Hospital where she is Head of Crystalline Arthritis Diseases and Rheumatology Director of the GCA Fast Track Clinic. Her primary research focus is calcium pyrophosphate crystal deposition (CPPD) disease. Dr. Tedeschi serves on the ACR Criteria Subcommittee and is section editor for Current Opinion in Rheumatology - Crystal Deposition Diseases.
CPPD Update: Let's Be Crystal Clear
Saturday, April 13, 2024
1:30 PM – 2:00 PM Central Time
Disclosure(s): Avalo Therapeutics: Consultant (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Terminated, December 19, 2022)
CPPD Update: Let's Be Crystal Clear
Saturday, April 13, 2024
1:30 PM – 1:50 PM Central Time
Disclosure(s): Avalo Therapeutics: Consultant (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Terminated, December 19, 2022)
Saturday, April 13, 2024
1:50 PM – 2:00 PM Central Time
Disclosure(s): Avalo Therapeutics: Consultant (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Terminated, December 19, 2022)
Saturday, April 13, 2024
4:40 PM – 5:40 PM Central Time
Disclosure(s): Avalo Therapeutics: Consultant (Ongoing); Merck: Consultant (Ongoing); Novartis: Consultant (Terminated, December 19, 2022)
